These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development. Wijesinghe P; Bollig-Fischer A Adv Exp Med Biol; 2016; 890():1-23. PubMed ID: 26703796 [TBL] [Abstract][Full Text] [Related]
4. Update on systemic therapy of advanced non-small-cell lung cancer. Cufer T; Knez L Expert Rev Anticancer Ther; 2014 Oct; 14(10):1189-203. PubMed ID: 25098682 [TBL] [Abstract][Full Text] [Related]
5. [Is chemotherapy still an option in oncogene-addicted non-small cell lung cancer? No]. Girard N Bull Cancer; 2015 Jun; 102(6 Suppl 1):S96-9. PubMed ID: 26118885 [TBL] [Abstract][Full Text] [Related]
6. Targeted Therapies for Non-Small Cell Lung Cancer: An Update on Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Inhibitors. Kreamer K; Riordan D Clin J Oncol Nurs; 2015 Dec; 19(6):734-42. PubMed ID: 26583637 [TBL] [Abstract][Full Text] [Related]
7. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers. Roskoski R Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216 [TBL] [Abstract][Full Text] [Related]
8. [Targeted therapies in non-small cell lung cancer in 2014]. Leduc C; Besse B Rev Mal Respir; 2015 Feb; 32(2):182-92. PubMed ID: 25704901 [TBL] [Abstract][Full Text] [Related]
9. Targeted therapies in the treatment of advanced non-small-cell lung cancer: update. Mendoza L Klin Onkol; 2009; 22(4):131-8. PubMed ID: 19731875 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for EGFR mutant and ALK positive NSCLC: Current data and future prospects. Chuang JC; Neal JW; Niu XM; Wakelee HA Lung Cancer; 2015 Oct; 90(1):1-7. PubMed ID: 26275476 [TBL] [Abstract][Full Text] [Related]
11. Predictors of biomarkers guiding targeted therapeutic strategies in locally advanced lung cancer. Cottini F; Lautenschlaeger T Cancer J; 2013; 19(3):263-71. PubMed ID: 23708073 [TBL] [Abstract][Full Text] [Related]
12. Targeting the MET gene for the treatment of non-small-cell lung cancer. Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409 [TBL] [Abstract][Full Text] [Related]
13. Targeted therapies and non-small-cell lung cancer: new developments. Gridelli C Curr Opin Oncol; 2007 Mar; 19(2):75-7. PubMed ID: 17272976 [No Abstract] [Full Text] [Related]
14. ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer. Govindan R; Mandrekar SJ; Gerber DE; Oxnard GR; Dahlberg SE; Chaft J; Malik S; Mooney M; Abrams JS; Jänne PA; Gandara DR; Ramalingam SS; Vokes EE Clin Cancer Res; 2015 Dec; 21(24):5439-44. PubMed ID: 26672084 [TBL] [Abstract][Full Text] [Related]
15. Improvement in lung cancer outcomes with targeted therapies: an update for family physicians. Rolfo C; Passiglia F; Ostrowski M; Farracho L; Ondøichová T; Dolcan A; Castiglia M; Remmen R; Papadimitriou K; Pauwels P J Am Board Fam Med; 2015; 28(1):124-33. PubMed ID: 25567833 [TBL] [Abstract][Full Text] [Related]
16. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer. Zhang K; Yuan Q J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005 [TBL] [Abstract][Full Text] [Related]
17. [Is chemotherapy still a valid option for oncogene-addicted lung cancer? Yes]. Besse B Bull Cancer; 2015 Jun; 102(6 Suppl 1):S93-5. PubMed ID: 26118884 [TBL] [Abstract][Full Text] [Related]
20. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations. Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]